肺癌手術 的英文怎麼說

中文拼音 [fèiáishǒushù]
肺癌手術 英文
lung cancer surgery
  • 肺 : 名詞（人和高等動物的呼吸器官） lungs
  • 癌 : 名詞[醫學] （惡性腫瘤） cancer; carcinoma
  • 手 : Ⅰ名詞1 （人體上肢前端能拿東西的部分） hand 2 （擅長某種技能的人或做某種事的人） a person doing or...
  • 術 : 術名詞1. （技藝; 技術; 學術） art; skill; technique 2. （方法; 策略） method; tactics 3. （姓氏） a surname
  • 肺癌 : carcinoma of the lungs; lung cancer
  1. Body gamma knife integrating precision actinotherapy, three - dimension adjustable actinotherapy and common actinotherapy, is a large irradiation neurosurgery device for body tumor. it is the ideal method for non - operation therapy of all kinds of lung cancer and liver cancer, firstly developed by shenzhen aowo intl. technology development co. ltd and passed the national mda certificate

    體部伽瑪刀是一種集精確放療三維適形放療和普通放療於一身的大型體部腫瘤放射外科治療設備，是非手術治療各種肺癌肝癌的理想手段，屬世界首創，由深圳奧沃國際科技發展有限公司研製開發，並通過國家mda認證。
  2. Objective : to review the surgical experience of intrapericardial pneumonectomy for lung cancer

    目的探討心包內處理血管的全肺切除術在提高肺癌手術療效中的作用。
  3. Pneumonectomy for non - small cell lung cancer carries an acceptable operative mortality and provides an important survival benefit

    因非小細胞肺癌而接受全肺切除術有可接受的手術死亡率並且能提供重要的生存益處。
  4. Results in the lung cancer group, the positive rate of telomerase activity in surgically resected lung cancer tissues was 91. 7 ( 33 out of 36 samples ), and 85. 7 ( 6 out of 7 samples ) and 71. 4 ( 5 out of 7 samples ) in fiberobronchoscopically collected tissues or cells and pleural effusion cells, respectively

    結果肺癌組： 36例手術切除肺癌組織中端粒酶陽性率為91 . 7 ， 7例纖維支氣管鏡活檢肺癌組織和7例癌性胸水細胞中端粒酶陽性例數分別為6例和5例；總檢出率為88 （ 44 50 ） 。
  5. Methods : we performed a retrospective study of 125 consecutive patients with synchronous multiple primary lung cancer who underwent operation between 1985 and 2006

    方法：我們進行了一項回顧性研究，從1985到2006年共125例連續的肺同步多發原發癌接受手術的患者納入研究范圍。
  6. Analysis of 118 cases of senior lung cancer operative

    118例老年人肺癌手術分析
  7. The influence of acupuncture on tumor necrosis factor level in patients undergoing an operation for lung cancer

    針刺對肺癌手術患者腫瘤壞死因子水平的影響
  8. Clinical study of interventional preoperative bronchial artery infusion chemotherapy combined with surgical resection for lung cancer

    術前支氣管動脈灌注化療在肺癌手術中的臨床研究
  9. Expression of apoptopsis regulatory proteins in primary resected non - small - cell lung cancer

    凋亡調節蛋白在手術切除的原發性非小細胞肺癌中的表達
  10. This article introduces the present development in post - operation treatment of lung cancer, liver cancer and stomach cancer, showing that the synthetic treatment by stages combined with traditional chinese medicine is the important way to prevent and treat the post - operation relapse and metastasis of tumors, and suggesting the optimized method for treatment

    本文介紹了肺癌、肝癌、胃癌術后治療的現狀，旨在說明聯合中醫藥的分階段綜合治療是防治腫瘤術后復發轉移的重要手段，並且提出了具體治療的優化方案。
  11. Study objectives : regional lymph node ( ln ) involvement affects the prognosis of patients with surgically resected non - small cell lung cancer ( nsclc )

    目的：區域淋巴結（ ln ）情況影響手術切除非小細胞肺癌（ nsclc ）患者的預后。
  12. Lung cancer is a common malignant tumor. its therapy draws more and more attention. main therapeutic regimens, including chemotherapy, radiotherapy and surgery, were summarized in this overview

    摘要肺癌系常見的惡性腫瘤，肺癌的治療受到廣泛關注，作者就目前小細胞性肺癌主要的治療方法（化學治療、放射治療、手術治療）進行扼要的綜述。
  13. The cost of a low - dose ct is below $ 200, the study authors stated, while the cost of surgery for stage i lung cancer is less than half the cost of late - stage treatment

    作者說，做一個低劑量ct的花費少於200美元，但i期肺癌的手術費用不到晚期肺癌治療費用的一半。
  14. As revealed in the recent published literature, stage i lung cancer has the best result after surgery, with five year survival rate around 50 - 75 %, followed by 30 - 50 % in stage and 5 - 25 % left in stage lung cancer

    當前醫學文獻顯示第一期非小細胞肺癌病人的手術預后最好，其五年存活率約在50 - 75 %之間，第二期則為30 - 50 % ，第三期則僅剩5 - 25 % 。
  15. Surgical removal of adrenal cortical carcinoma complicated by intra - atrial tumor thrombus is very difficult and risky if the removal of thrombus is incomplete, leading possibly to pulmonary embolism

    摘要腎上腺皮質腺癌並發的心房內腫瘤血栓，手術摘除是非常困難的，也容易因腫瘤血栓的摘除不完全，造成肺栓塞。
  16. If the majority of excess early cancers found through screening are unlikely to progress rapidly to a point where they cause clinically significant disease or death, then the thoracic surgeries performed to remoe them may be insufficiently beneficial to justify the resulting morbidities, " the authors write

    如果篩查發現的過早期肺癌中大部分不太可能迅速進展到導致明顯臨床癥狀或者死亡，外科手術切除帶來的益處就不足以抵消其導致的增加的發病率」作者寫道。
  17. Conclusions : provided there is an appropriate selection process, patients with synchronous multiple primary lung cancer are expected to benefit from surgery

    結論：假若這個是一個適當的選擇過程，肺同步多發原發癌患者將從手術中獲益。
分享友人
分享到 Line

分享到臉書